Market revenue in 2022 | USD 173.9 million |
Market revenue in 2030 | USD 271.0 million |
Growth rate | 5.7% (CAGR from 2022 to 2030) |
Largest segment | Estrogen and progesterone replacement therapy |
Fastest growing segment | Parathyroid Hormone replacement |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Estrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement |
Key market players worldwide | Eli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.
Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 57.79% in 2022. Horizon Databook has segmented the South Africa hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa's hormonal replacement therapy market is expected t o grow over the forecast period. Increasing prevalence of hormone-related diseases, such as male hypogonadism caused due t o failure o f the testis to produce testosterone, is also expected t o fuel the market growth.
Hence, increasing incidence of diabetes is expected to consequently increase the prevalence o f male hypogonadism over the forecast period. It is usually treated with testosterone replacement therapy to maintain normal testosterone hormone levels.
However, organizations such as UNICEF are providing funding to support the growth of healthcare system, which may help bridge the gap i n healthcare, thereby contributing to market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa hormone replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into South Africa hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account